- Home
- PCB vs ABEO Comparison
PCB vs ABEO Comparison
Compare PCB & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCB
- ABEO
- Stock Information
- Founded
- PCB 2003
- ABEO 1974
- Country
- PCB United States
- ABEO United States
- Employees
- PCB N/A
- ABEO N/A
- Industry
- PCB Major Banks
- ABEO Biotechnology: Pharmaceutical Preparations
- Sector
- PCB Finance
- ABEO Health Care
- Exchange
- PCB Nasdaq
- ABEO Nasdaq
- Market Cap
- PCB 289.7M
- ABEO 332.0M
- IPO Year
- PCB N/A
- ABEO 1980
- Fundamental
- Price
- PCB $22.10
- ABEO $6.83
- Analyst Decision
- PCB Hold
- ABEO Strong Buy
- Analyst Count
- PCB 2
- ABEO 6
- Target Price
- PCB $22.25
- ABEO $18.17
- AVG Volume (30 Days)
- PCB 26.5K
- ABEO 702.3K
- Earning Date
- PCB 10-23-2025
- ABEO 08-14-2025
- Dividend Yield
- PCB 3.62%
- ABEO N/A
- EPS Growth
- PCB 29.75
- ABEO N/A
- EPS
- PCB 2.14
- ABEO 0.99
- Revenue
- PCB $102,259,000.00
- ABEO $400,000.00
- Revenue This Year
- PCB $22.59
- ABEO N/A
- Revenue Next Year
- PCB $9.32
- ABEO $339.63
- P/E Ratio
- PCB $10.33
- ABEO $6.91
- Revenue Growth
- PCB 9.08
- ABEO N/A
- 52 Week Low
- PCB $16.00
- ABEO $3.93
- 52 Week High
- PCB $22.45
- ABEO $7.54
- Technical
- Relative Strength Index (RSI)
- PCB 57.65
- ABEO 52.71
- Support Level
- PCB $21.97
- ABEO $6.70
- Resistance Level
- PCB $22.41
- ABEO $7.15
- Average True Range (ATR)
- PCB 0.38
- ABEO 0.31
- MACD
- PCB 0.05
- ABEO -0.02
- Stochastic Oscillator
- PCB 73.08
- ABEO 46.62
About PCB PCB Bancorp
PCB Bancorp is a bank holding company, which engages in the provision of consumer and commercial banking services. It provides Personal, Business, and Loan services, which provide banking, lending, and digital, tools, home loans, and others. Also, it offers a broad range of loans, deposits, and other products and services predominantly to small and middle-market businesses and individuals. The company provided it's services in Los Angeles and Orange Counties, California; Bellevue, Washington; and Atlanta, Georgia.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.